Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

XELJANZ / XELJANZ XR How Supplied/Storage and Handling (tofacitinib)

16 HOW SUPPLIED/STORAGE AND HANDLING

How supplied information for XELJANZ/XELJANZ XR is shown in Table 22.

Table 22: How Supplied Information for XELJANZ/XELJANZ XR
Bottle Size
(number of tablets)
NDC Number
XELJANZ
5 mg tofacitinib tablets

White, round, immediate-release film-coated tablets, debossed with "Pfizer" on one side, and "JKI 5" on the other side
60NDC 0069-1001-01
XELJANZ
10 mg tofacitinib tablets

Blue, round, immediate-release film-coated tablets, debossed with "Pfizer" on one side, and "JKI 10" on the other side
60NDC 0069-1002-01
XELJANZ XR
11 mg tofacitinib tablets

Pink, oval, extended-release film-coated tablets with a drilled hole at one end of the tablet band and "JKI 11" printed on one side of the tablet
30NDC 0069-0501-30
XELJANZ XR
22 mg tofacitinib tablets

Beige, oval, extended-release film-coated tablets with a drilled hole at one end of the tablet band and "JKI 22" printed on one side of the tablet
30NDC 0069-0502-30

How supplied information for XELJANZ Oral Solution is shown in Table 23.

Table 23: How Supplied Information for XELJANZ Oral Solution
Bottle Fill
(volume mL)
NDC Number
XELJANZ Oral Solution
1 mg/mL tofacitinib oral solution
Clear, colorless solution
240 mLNDC 0069-1029-02

XELJANZ/XELJANZ XR

Store XELJANZ/XELJANZ XR at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature].

Do not repackage.

XELJANZ Oral Solution

XELJANZ 1 mg/ mL oral solution is a clear, colorless solution that contains 1 mg of tofacitinib. It is packaged in HDPE bottles as follows:

Each bottle is packaged with one press-in bottle adapter and one 5 mL oral dosing syringe with 3.2 mL, 4 mL, and 5 mL gradations. The press-in bottle adapter and oral dosing syringe are not made with natural rubber latex.

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). [See USP Controlled Room Temperature].

Store in the original bottle and carton to protect from light.

Use contents of bottle within 60 days of opening.

Discard remaining oral solution after 60 days.

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event